The application of AI to disease management and treatment is rapidly evolving and providing itself invaluable, one therapeutic area that has quickly demonstrated benefits from the application is infectious disease.
As the industry prepares for the new age of hybrid and decentralized trials there is a heightened focus on data (quality, volume and validity), metrics and operational efficiency. Learn more at SCOPE 2020.
With unrelenting pressures to rein in budgets and cycle times, stakeholders are turning to quality as a solution, starting with building it into study startup and bringing change to entrenched silos that stall trial operations.
The Association of Clinical Research Organizations (ACRO) provides the needed forum for leading CROs to collaborate and discuss this rapidly changing world of technology, regulatory requirements /guidance and industry standards in clinical research.